Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr₹0.78 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹1.01 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr
Mar2021₹0.78 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr
16,663.92
Mar2021 ₹0.78 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,849.0 Cr 4.5% 15.2% -11.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

4.5%

15.2%

-11.4%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses